BMC Medical Co., Ltd., a prominent player in the medical device industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1993, the company has established itself as a leader in the development and manufacturing of high-quality medical equipment, particularly in respiratory care and anaesthesia. BMC Medical is renowned for its innovative products, including advanced ventilators and CPAP devices, which are designed to enhance patient comfort and treatment efficacy. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted name in healthcare solutions. With a strong market presence and a focus on quality, BMC Medical continues to contribute to the global healthcare landscape, ensuring better outcomes for patients worldwide.
How does BMC Medical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BMC Medical Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BMC Medical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. The company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions figures available, it is important to note that BMC Medical Co., Ltd. has not inherited any emissions data from a parent or related organization, indicating that their climate strategy is currently independent. The lack of reported emissions and reduction initiatives suggests that the company may need to enhance its focus on sustainability and climate commitments to align with industry best practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BMC Medical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
